An additional limitation is the unavailability or high missingness of clinical variables in the first 6 h that may inform corticosteroid use in pneumonia including CRP as demonstrated in prior studies [16, 17]. The gene discussed is CRP; the disease is susceptibility to pneumonia measurement.